A continuous sorting technique of stem cells on a DLD microfluidic platform may greatly advance cell therapy.
List view / Grid view
Agency for Science Technology and Research (A*STAR)
Researchers have identified an important gene that could enable more targeted treatment for cancer.
Plasticell, a developer of stem cell technologies and cell-based therapies, has signed agreements with the Agency for Science, Technology and Research (A*STAR) and the Nanyang Technological University (NTU) to progress its therapeutic stem cell pipeline.